Skip to content

aTyr Pharma ATYR Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Merck & Co. logo
Merck & Co.MRK
$157M+726%
United Therapeutics logo
United TherapeuticsUTHR
$68.3M+311%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$19.91M
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$228.35M
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$60.88M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$321K-33.7%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$54.88M-88.2%
Enterprise value$57.17M
P/S288.8×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is aTyr Pharma's stock issuance proceeds?
aTyr Pharma (ATYR) reported stock issuance proceeds of $0 in Q1 2026.
How has aTyr Pharma's stock issuance proceeds changed year-over-year?
aTyr Pharma's stock issuance proceeds decreased by 100.0% year-over-year, from $2K to $0.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.